TY - JOUR
T1 - Synthesis of linear and angular aryl-morpholino-naphth-oxazines, their DNA-PK, PI3K, PDE3A and antiplatelet activity
AU - Morrison, Rick
AU - Zheng, Zhaohua
AU - Jennings, Ian G.
AU - Thompson, Philip E.
AU - Al-Rawi, Jasim M A
PY - 2016
Y1 - 2016
N2 - To continue our study of 2-morpholino-benzoxazine based compounds, which show useful activity against PI3K family enzymes or antiplatelet activity, we designed and synthesized a series of linear 6.7-fused, 5,6-angular fused and 7,8-angular fused-aryl-morpholino-naphth-oxazines. The compounds were prepared from substituted 2-hydroxynaphthoic acid to give the corresponding thioxo analogues 8, 9, 15 and 19. The thioxo products were then converted to the morpholino substituted analogue. The aryl group was introduced by Suzuki coupling of bromo precursors. The products were evaluated for activity at PI3K family enzymes and as platelet aggregation inhibitors and compared to reported unsubstituted analogues. The linear 6.7-fused product 13a and 13b were moderated potent but selective PI3Kδ isoform inhibitors (IC50 = 7.7 and 5.61 μM). Good antiplatelet activity was noticed for the angular 7,8-fused compounds 22a, b, k and l with IC50 = 3.0,14.0, 2.0 and 5.0 μM respectively. The antiplatelet activity is independent of PDE3.
AB - To continue our study of 2-morpholino-benzoxazine based compounds, which show useful activity against PI3K family enzymes or antiplatelet activity, we designed and synthesized a series of linear 6.7-fused, 5,6-angular fused and 7,8-angular fused-aryl-morpholino-naphth-oxazines. The compounds were prepared from substituted 2-hydroxynaphthoic acid to give the corresponding thioxo analogues 8, 9, 15 and 19. The thioxo products were then converted to the morpholino substituted analogue. The aryl group was introduced by Suzuki coupling of bromo precursors. The products were evaluated for activity at PI3K family enzymes and as platelet aggregation inhibitors and compared to reported unsubstituted analogues. The linear 6.7-fused product 13a and 13b were moderated potent but selective PI3Kδ isoform inhibitors (IC50 = 7.7 and 5.61 μM). Good antiplatelet activity was noticed for the angular 7,8-fused compounds 22a, b, k and l with IC50 = 3.0,14.0, 2.0 and 5.0 μM respectively. The antiplatelet activity is independent of PDE3.
KW - 5,6-Angular fused and 7,8-angular fused-aryl-morpholino-naphth-oxazines
KW - 6.7-Fused
KW - DNA-PK
KW - PDE3A antiplatelet activity
KW - PI3K
UR - http://www.scopus.com/inward/record.url?scp=84993960824&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2016.10.003
DO - 10.1016/j.bmcl.2016.10.003
M3 - Article
AN - SCOPUS:84993960824
SN - 0960-894X
VL - 26
SP - 5534
EP - 5538
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 22
ER -